Pemvidutide

N/A

Report date: 2023/10/27 09:20:32

Base Information

Drug NamePemvidutide
Drug Alias NameALT-801(Altimmune)SP-1373VPD-107
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucagon receptor agonists
TargetsGlucagon-like peptide 1 receptorGlucagon receptor
Therapy Area/IndicationsAlcoholismOverweightObesity +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto RicoAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVelocity Pharmaceutical Development
China Registration ClassN/A

Develop Information

Active CompaniesAltimmune Inc
Inactive CompaniesN/A
Active IndicationsAlcoholismOverweightObesity +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A